Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

BridgeBio Pharma (BBIO) Interest Coverage Ratio (2019 - 2025)

Historic Interest Coverage Ratio for BridgeBio Pharma (BBIO) over the last 7 years, with Q3 2025 value amounting to 12.37.

  • BridgeBio Pharma's Interest Coverage Ratio fell 4875.63% to 12.37 in Q3 2025 from the same period last year, while for Sep 2025 it was 5.03, marking a year-over-year increase of 1714.31%. This contributed to the annual value of 5.97 for FY2024, which is 2007.04% up from last year.
  • BridgeBio Pharma's Interest Coverage Ratio amounted to 12.37 in Q3 2025, which was down 4875.63% from 3.57 recorded in Q2 2025.
  • BridgeBio Pharma's Interest Coverage Ratio's 5-year high stood at 0.01 during Q1 2024, with a 5-year trough of 17.2 in Q1 2021.
  • Moreover, its 5-year median value for Interest Coverage Ratio was 7.65 (2024), whereas its average is 7.77.
  • In the last 5 years, BridgeBio Pharma's Interest Coverage Ratio surged by 10023.31% in 2024 and then crashed by 1704792.92% in 2025.
  • Quarter analysis of 5 years shows BridgeBio Pharma's Interest Coverage Ratio stood at 10.94 in 2021, then skyrocketed by 40.92% to 6.46 in 2022, then tumbled by 35.4% to 8.75 in 2023, then increased by 13.41% to 7.58 in 2024, then tumbled by 63.19% to 12.37 in 2025.
  • Its Interest Coverage Ratio stands at 12.37 for Q3 2025, versus 3.57 for Q2 2025 and 2.48 for Q1 2025.